by Cardio Diagnostics Inc | Sep 29, 2019 | News
Cardio Diagnostics received $225K in National Institutes of Health (NIH) funding to further develop our integrated genetic-epigenetic coronary heart disease risk screening technology.
by Cardio Diagnostics Inc | May 3, 2019 | News
Cardio Diagnostics won the Biotech Innovation Showcase Award and received a $5,000 grand prize at the annual IowaBio Partnering for Growth Conference.
by Cardio Diagnostics Inc | Dec 22, 2018 | News
Cardio Diagnostics’ simple DNA test is better at identifying those at risk for coronary heart disease than standard approaches. This manuscript details the performance of our technology and highlights its ability to more sensitively (by >30%) identify those at risk...
by Cardio Diagnostics Inc | Aug 31, 2018 | News
We are very excited to announce that Cardio Diagnostics has partnered with Intermountain Healthcare to independently validate our integrated genetic-epigenetic technology!
by Cardio Diagnostics Inc | Jan 8, 2018 | News
See how our improved method for detecting coronary heart disease could have a substantial clinical impact. Our manuscript describing the integrated genetic-epigenetic prediction of coronary heart disease (CHD) has just been published online. Building on the idea that...